Edwards Historical Financial Ratios

EW Stock

USD 89.20 1.08 1.20%

Edwards Lifesciences is recently reporting on over 114 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 4.82 will help investors to properly organize and evaluate Edwards Lifesciences Corp financial condition quickly.

Quick Ratio Current Ratio

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edwards Lifesciences Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing.

About Edwards Financial Ratios Analysis

Edwards Lifesciences CorpFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Edwards Lifesciences investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Edwards financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Edwards Lifesciences history.

Edwards Lifesciences Financial Ratios Chart

Edwards Lifesciences Corp financial ratios usually calculated using numerical values taken directly from Edwards Lifesciences financial statements such as income statements or balance sheets. They help investors to obtain meaningful information about Edwards Lifesciences. Most financial ratios help to conduct quantitative analysis to assess vital information about the company's valuation as well as profitability and liquidity indicators such as leverage, growth, profit margins, and different types of rates of return.

At this time, Edwards Lifesciences' POCF Ratio is fairly stable compared to the past year. PFCF Ratio is likely to climb to 77.16 in 2024, whereas Dividend Yield is likely to drop 0 in 2024.

Price To Sales Ratio Dividend Yield Ptb Ratio Days Sales Outstanding

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Edwards Lifesciences Corp stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Edwards Lifesciences sales, a figure that is much harder to manipulate than other Edwards Lifesciences Corp multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.

Dividend Yield

Dividend Yield is Edwards Lifesciences Corp dividend as a percentage of Edwards Lifesciences stock price. Edwards Lifesciences Corp dividend yield is a measure of Edwards Lifesciences stock productivity, which can be interpreted as interest rate earned on an Edwards Lifesciences investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Most ratios from Edwards Lifesciences' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Edwards Lifesciences Corp current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edwards Lifesciences Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing.

At this time, Edwards Lifesciences' POCF Ratio is fairly stable compared to the past year. PFCF Ratio is likely to climb to 77.16 in 2024, whereas Dividend Yield is likely to drop 0 in 2024.

	2021	2022	2023	2024 (projected)
Dividend Yield	0.001964	0.00317	0.003673	0.003489
Price To Sales Ratio	15.43	8.58	7.7	4.36

Dividend Yield Price To Sales Ratio

Edwards Lifesciences fundamentals Correlations

	Price To Sales Ratio	Dividend Yield	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Invested Capital	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Payout Ratio	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality
Price To Sales Ratio		-0.55	0.97	-0.67	0.52	-0.6	-0.56	0.83	-0.72	0.97	1.0	0.77	0.73	-0.41	0.57	0.28	-0.05	-0.54	0.56	0.66	-0.02	-0.58	-0.04	0.61	-0.29	-0.29
Dividend Yield	-0.55		-0.49	0.51	-0.57	0.42	0.41	-0.58	0.4	-0.49	-0.54	-0.53	-0.3	0.3	-0.56	-0.32	0.28	0.12	-0.55	-0.59	0.01	0.95	0.02	-0.54	-0.04	0.32
Ptb Ratio	0.97	-0.49		-0.6	0.41	-0.68	-0.62	0.77	-0.82	1.0	0.97	0.7	0.77	-0.43	0.46	0.25	0.03	-0.62	0.51	0.62	-0.07	-0.49	-0.09	0.57	-0.4	-0.27
Days Sales Outstanding	-0.67	0.51	-0.6		-0.5	0.3	0.2	-0.78	0.41	-0.6	-0.67	-0.78	-0.4	0.31	-0.58	-0.25	-0.25	0.09	-0.71	-0.36	-0.07	0.66	-0.38	-0.26	0.36	0.24
Book Value Per Share	0.52	-0.57	0.41	-0.5		-0.54	-0.52	0.74	-0.3	0.41	0.52	0.65	0.32	-0.75	0.96	0.83	-0.31	0.0	0.79	0.86	0.02	-0.67	-0.15	0.79	0.12	-0.73
Free Cash Flow Yield	-0.6	0.42	-0.68	0.3	-0.54		0.94	-0.49	0.69	-0.68	-0.61	-0.4	-0.73	0.83	-0.53	-0.66	-0.15	0.37	-0.62	-0.79	-0.06	0.39	0.35	-0.75	0.53	0.74
Invested Capital	-0.56	0.41	-0.62	0.2	-0.52	0.94		-0.5	0.53	-0.62	-0.56	-0.44	-0.65	0.78	-0.56	-0.63	-0.19	0.22	-0.59	-0.72	-0.01	0.37	0.22	-0.67	0.54	0.79
Operating Cash Flow Per Share	0.83	-0.58	0.77	-0.78	0.74	-0.49	-0.5		-0.48	0.77	0.83	0.98	0.43	-0.5	0.84	0.45	-0.03	-0.17	0.77	0.62	0.03	-0.67	0.25	0.51	-0.2	-0.43
Capex To Depreciation	-0.72	0.4	-0.82	0.41	-0.3	0.69	0.53	-0.48		-0.82	-0.72	-0.35	-0.79	0.45	-0.26	-0.3	0.0	0.85	-0.44	-0.61	0.15	0.38	0.46	-0.64	0.33	0.24
Pb Ratio	0.97	-0.49	1.0	-0.6	0.41	-0.68	-0.62	0.77	-0.82		0.97	0.7	0.77	-0.43	0.46	0.25	0.03	-0.62	0.51	0.62	-0.07	-0.49	-0.09	0.57	-0.4	-0.27
Ev To Sales	1.0	-0.54	0.97	-0.67	0.52	-0.61	-0.56	0.83	-0.72	0.97		0.77	0.72	-0.42	0.57	0.28	-0.04	-0.54	0.56	0.66	-0.01	-0.57	-0.04	0.6	-0.29	-0.29
Free Cash Flow Per Share	0.77	-0.53	0.7	-0.78	0.65	-0.4	-0.44	0.98	-0.35	0.7	0.77		0.31	-0.4	0.79	0.34	0.05	-0.04	0.72	0.48	0.05	-0.63	0.43	0.35	-0.23	-0.36
Roic	0.73	-0.3	0.77	-0.4	0.32	-0.73	-0.65	0.43	-0.79	0.77	0.72	0.31		-0.59	0.32	0.44	0.02	-0.68	0.34	0.6	0.01	-0.29	-0.42	0.63	-0.4	-0.39
Inventory Turnover	-0.41	0.3	-0.43	0.31	-0.75	0.83	0.78	-0.5	0.45	-0.43	-0.42	-0.4	-0.59		-0.7	-0.95	-0.01	0.13	-0.68	-0.81	-0.07	0.34	0.32	-0.78	0.28	0.8
Net Income Per Share	0.57	-0.56	0.46	-0.58	0.96	-0.53	-0.56	0.84	-0.26	0.46	0.57	0.79	0.32	-0.7		0.75	-0.17	0.08	0.81	0.76	0.0	-0.68	0.06	0.66	-0.02	-0.75
Days Of Inventory On Hand	0.28	-0.32	0.25	-0.25	0.83	-0.66	-0.63	0.45	-0.3	0.25	0.28	0.34	0.44	-0.95	0.75		-0.18	-0.03	0.64	0.8	0.05	-0.37	-0.36	0.79	-0.03	-0.78
Payables Turnover	-0.05	0.28	0.03	-0.25	-0.31	-0.15	-0.19	-0.03	0.0	0.03	-0.04	0.05	0.02	-0.01	-0.17	-0.18		0.18	0.23	-0.29	0.08	0.16	0.45	-0.32	-0.88	-0.16
Capex To Revenue	-0.54	0.12	-0.62	0.09	0.0	0.37	0.22	-0.17	0.85	-0.62	-0.54	-0.04	-0.68	0.13	0.08	-0.03	0.18		-0.02	-0.36	0.09	0.06	0.64	-0.46	0.08	-0.1
Cash Per Share	0.56	-0.55	0.51	-0.71	0.79	-0.62	-0.59	0.77	-0.44	0.51	0.56	0.72	0.34	-0.68	0.81	0.64	0.23	-0.02		0.7	0.17	-0.7	0.1	0.63	-0.36	-0.69
Pocfratio	0.66	-0.59	0.62	-0.36	0.86	-0.79	-0.72	0.62	-0.61	0.62	0.66	0.48	0.6	-0.81	0.76	0.8	-0.29	-0.36	0.7		-0.04	-0.62	-0.48	0.98	-0.02	-0.72
Interest Coverage	-0.02	0.01	-0.07	-0.07	0.02	-0.06	-0.01	0.03	0.15	-0.07	-0.01	0.05	0.01	-0.07	0.0	0.05	0.08	0.09	0.17	-0.04		0.0	0.09	-0.04	-0.11	0.07
Payout Ratio	-0.58	0.95	-0.49	0.66	-0.67	0.39	0.37	-0.67	0.38	-0.49	-0.57	-0.63	-0.29	0.34	-0.68	-0.37	0.16	0.06	-0.7	-0.62	0.0		-0.07	-0.56	0.0	0.43
Capex To Operating Cash Flow	-0.04	0.02	-0.09	-0.38	-0.15	0.35	0.22	0.25	0.46	-0.09	-0.04	0.43	-0.42	0.32	0.06	-0.36	0.45	0.64	0.1	-0.48	0.09	-0.07		-0.61	-0.25	0.19
Pfcf Ratio	0.61	-0.54	0.57	-0.26	0.79	-0.75	-0.67	0.51	-0.64	0.57	0.6	0.35	0.63	-0.78	0.66	0.79	-0.32	-0.46	0.63	0.98	-0.04	-0.56	-0.61		0.02	-0.66
Days Payables Outstanding	-0.29	-0.04	-0.4	0.36	0.12	0.53	0.54	-0.2	0.33	-0.4	-0.29	-0.23	-0.4	0.28	-0.02	-0.03	-0.88	0.08	-0.36	-0.02	-0.11	0.0	-0.25	0.02		0.33
Income Quality	-0.29	0.32	-0.27	0.24	-0.73	0.74	0.79	-0.43	0.24	-0.27	-0.29	-0.36	-0.39	0.8	-0.75	-0.78	-0.16	-0.1	-0.69	-0.72	0.07	0.43	0.19	-0.66	0.33

Click cells to compare fundamentals

Edwards Lifesciences Account Relationship Matchups

Edwards Lifesciences fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Price To Sales Ratio	11.18	12.95	15.43	8.58	7.7	4.36
Dividend Yield	3.89E-4	0.002474	0.001964	0.00317	0.003673	0.003489
Ptb Ratio	11.71	12.42	13.84	7.95	6.96	4.82
Days Sales Outstanding	50.29	50.16	46.38	47.41	50.87	60.3
Book Value Per Share	6.64	7.35	9.36	9.38	10.96	11.51
Free Cash Flow Yield	0.0185	0.0114	0.0174	0.0206	0.0136	0.0129
Invested Capital	0.19	0.16	0.15	0.12	0.1	0.0993
Operating Cash Flow Per Share	1.48	1.89	1.69	2.78	1.97	1.55
Stock Based Compensation To Revenue	0.0179	0.0191	0.0187	0.0211	0.0236	0.0293
Pb Ratio	11.71	12.42	13.84	7.95	6.96	4.82
Ev To Sales	8.57	11.06	12.84	15.4	7.63	4.39
Free Cash Flow Per Share	1.3	1.09	1.44	1.04	2.25	1.54
Inventory Turnover	1.74	1.35	1.72	1.23	1.18	1.12
Net Income Per Share	1.68	1.32	2.41	2.46	2.31	2.43
Days Of Inventory On Hand	209.91	271.0	212.38	295.78	309.03	324.48
Payables Turnover	6.18	5.5	6.11	5.35	6.85	4.78
Capex To Revenue	(0.064)	(0.0929)	(0.063)	(0.0492)	(0.0443)	(0.0466)
Pocfratio	41.2	53.87	46.62	37.91	51.64	54.22
Interest Coverage	55.4	103.06	73.29	91.07	87.16	46.38
Pfcf Ratio	53.93	87.79	57.58	48.44	73.49	77.16
Days Payables Outstanding	59.09	66.37	59.77	68.21	53.28	95.13
Ev To Operating Cash Flow	40.78	53.41	46.52	37.85	51.14	53.7
Pe Ratio	46.42	68.98	53.72	30.35	32.99	31.34
Ev To Free Cash Flow	53.38	87.03	57.46	48.36	72.77	76.41
Earnings Yield	0.0215	0.0145	0.0186	0.033	0.0303	0.0169
Net Debt To E B I T D A	(0.0865)	(0.38)	(0.28)	(0.0425)	(0.23)	(0.22)
Current Ratio	3.31	3.46	3.08	3.03	3.38	2.33
Tangible Book Value Per Share	4.23	4.93	6.97	7.04	8.3	8.72
Receivables Turnover	7.26	7.28	7.87	7.7	7.18	5.45

Pair Trading with Edwards Lifesciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Edwards Lifesciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edwards Lifesciences will appreciate offsetting losses from the drop in the long position's value.

Moving together with Edwards Stock

0.75

ENSG

Ensign Group Financial Report 24th of April 2024

Pair Corr

Moving against Edwards Stock

0.83	XRAY	Dentsply Sirona Financial Report 1st of May 2024	Pair Corr
0.83	INNV	InnovAge Holding Corp Financial Report 14th of May 2024	Pair Corr
0.77	LUCY	Innovative Eyewear	Pair Corr
0.71	MMSI	Merit Medical Systems Financial Report 24th of April 2024	Pair Corr
0.69	FIGS	Figs Inc Financial Report 2nd of May 2024	Pair Corr

The ability to find closely correlated positions to Edwards Lifesciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Edwards Lifesciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Edwards Lifesciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Edwards Lifesciences Corp to buy it.

The correlation of Edwards Lifesciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Edwards Lifesciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Edwards Lifesciences Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Edwards Lifesciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Edwards Lifesciences Corp is a strong investment it is important to analyze Edwards Lifesciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Edwards Lifesciences' future performance. For an informed investment choice regarding Edwards Stock, refer to the following important reports:

How To Invest In Edwards

Details

Is Edwards Stock a good investment?

Details

What is Edwards Lifesciences' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Complementary Tools for Edwards Stock analysis

When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.

	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	Global Correlations Find global opportunities by holding instruments from different markets
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	Commodity Channel Use Commodity Channel Index to analyze current equity momentum
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency

Is Edwards Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Edwards Lifesciences. If investors know Edwards will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Edwards Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.06)

Earnings Share

2.3

Revenue Per Share

9.897

Quarterly Revenue Growth

0.138

Return On Assets

0.1225

The market value of Edwards Lifesciences Corp is measured differently than its book value, which is the value of Edwards that is recorded on the company's balance sheet. Investors also form their own opinion of Edwards Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Edwards Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Edwards Lifesciences' market value can be influenced by many factors that don't directly affect Edwards Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Edwards Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Edwards Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Edwards Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Edwards Historical Financial Ratios

About Edwards Financial Ratios Analysis

Edwards Lifesciences Financial Ratios Chart

Price To Sales Ratio

Dividend Yield

Ptb Ratio

Edwards Lifesciences fundamentals Correlations

Edwards Lifesciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Edwards Lifesciences fundamentals Accounts

Pair Trading with Edwards Lifesciences

Moving together with Edwards Stock

Moving against Edwards Stock

Complementary Tools for Edwards Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ev To Sales	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Free Cash Flow Per Share	+ 0.98	Operating Cash Flow Per Share
Pfcf Ratio	+ 0.98	Pocfratio
Ptb Ratio	+ 0.97	Price To Sales Ratio
Pb Ratio	+ 0.97	Price To Sales Ratio

Days Of Inventory On Hand	- 0.95	Inventory Turnover
Days Payables Outstanding	- 0.88	Payables Turnover
Pb Ratio	- 0.82	Capex To Depreciation
Capex To Depreciation	- 0.82	Ptb Ratio
Pocfratio	- 0.81	Inventory Turnover
Roic	- 0.79	Capex To Depreciation